Vinayak Muralidhar

Vinayak Muralidhar

UNVERIFIED PROFILE

Are you Vinayak Muralidhar?   Register this Author

Register author
Vinayak Muralidhar

Vinayak Muralidhar

Publications by authors named "Vinayak Muralidhar"

Are you Vinayak Muralidhar?   Register this Author

55Publications

1506Reads

15Profile Views

Genomic Validation of 3-Tiered Clinical Subclassification of High-Risk Prostate Cancer.

Int J Radiat Oncol Biol Phys 2019 Nov 2;105(3):621-627. Epub 2019 Jul 2.

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.06.2510DOI Listing
November 2019

United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015.

Prostate Cancer Prostatic Dis 2019 Oct 7. Epub 2019 Oct 7.

Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41391-019-0175-9DOI Listing
October 2019

Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer.

Cancer 2019 Sep 31;125(18):3164-3171. Epub 2019 May 31.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32202DOI Listing
September 2019

Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen Level.

J Natl Compr Canc Netw 2019 Aug;17(8):941-948

bDepartment of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2018.7283DOI Listing
August 2019

Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapy.

Brachytherapy 2019 Mar - Apr;18(2):198-203. Epub 2019 Jan 10.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2018.12.001DOI Listing
July 2019

A comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer.

Brachytherapy 2019 Mar - Apr;18(2):186-191. Epub 2019 Jan 10.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2018.12.007DOI Listing
July 2019

Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer.

Eur Urol Focus 2019 01 17;5(1):69-76. Epub 2017 Jun 17.

Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2017.05.011DOI Listing
January 2019

Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer.

Eur Urol 2019 01 24;75(1):35-41. Epub 2018 Oct 24.

Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.08.033DOI Listing
January 2019

Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer.

Ann Surg Oncol 2018 Dec 8;25(13):4027-4034. Epub 2018 Oct 8.

Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-018-6832-8DOI Listing
December 2018

Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance.

Clin Genitourin Cancer 2018 06 9;16(3):226-234. Epub 2017 Nov 9.

Harvard Medical School, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.10.013DOI Listing
June 2018

Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent Divorce.

Am J Med 2018 05 16;131(5):517-523. Epub 2018 Mar 16.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2017.11.039DOI Listing
May 2018

Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer.

Urol Oncol 2018 04 21;36(4):157.e15-157.e20. Epub 2017 Dec 21.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439173061
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2017.11.022DOI Listing
April 2018

Travel distance and stereotactic body radiotherapy for localized prostate cancer.

Cancer 2018 03 12;124(6):1141-1149. Epub 2017 Dec 12.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31190DOI Listing
March 2018

Lack of Apparent Survival Benefit With Use of Androgen Deprivation Therapy in Patients With High-risk Prostate Cancer Receiving Combined External Beam Radiation Therapy and Brachytherapy.

Int J Radiat Oncol Biol Phys 2018 01 9;100(1):53-58. Epub 2017 Sep 9.

Harvard Medical School, Boston, Massachusetts; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016173384
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2017.08.046DOI Listing
January 2018

Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer.

Int J Radiat Oncol Biol Phys 2017 11 31;99(4):904-911. Epub 2017 Jul 31.

Harvard Medical School, Boston, Massachusetts; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.07.034DOI Listing
November 2017

Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer.

Clin Genitourin Cancer 2017 10 28;15(5):563-569.e3. Epub 2016 Oct 28.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.10.011DOI Listing
October 2017

Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy.

Urol Oncol 2017 09 19;35(9):542.e25-542.e32. Epub 2017 May 19.

Harvard Medical School, Boston, MA; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2017.04.018DOI Listing
September 2017

Characteristics and national trends of patients receiving treatment of the primary tumor for metastatic prostate cancer.

Prostate Int 2017 Sep 18;5(3):89-94. Epub 2017 Apr 18.

Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prnil.2017.04.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551914PMC
September 2017

Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer.

Brachytherapy 2016 Nov - Dec;15(6):695-700. Epub 2016 Aug 12.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2016.07.001DOI Listing
July 2017

National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer.

Int J Radiat Oncol Biol Phys 2017 06 21;98(2):338-343. Epub 2017 Feb 21.

Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.02.020DOI Listing
June 2017

Maximizing resources in the local treatment of prostate cancer: A summary of cost-effectiveness studies.

Urol Oncol 2017 02 27;35(2):76-85. Epub 2016 Jul 27.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.06.003DOI Listing
February 2017

Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?

Int J Radiat Oncol Biol Phys 2016 10 27;96(2):313-317. Epub 2016 May 27.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.05.022DOI Listing
October 2016

Merkel Cell Carcinoma: A Population Analysis on Survival.

J Natl Compr Canc Netw 2016 10;14(10):1247-1257

From Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School; Department of Radiation Oncology, and Department of Medical Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute; and Merkel Cell Carcinoma Clinic, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0134DOI Listing
October 2016

Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center.

Clin Genitourin Cancer 2016 08 17;14(4):e299-305. Epub 2015 Dec 17.

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.12.008DOI Listing
August 2016

Recent relocation and decreased survival following a cancer diagnosis.

Prev Med 2016 08 7;89:245-250. Epub 2016 Jun 7.

Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health/Center for Community Based Research, Dana-Farber Cancer Institute, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ypmed.2016.06.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969106PMC
August 2016

Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?

BJU Int 2016 Jul 22;118(1):95-101. Epub 2015 Aug 22.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13239DOI Listing
July 2016

Risk of prostate cancer mortality in men with a history of prior cancer.

BJU Int 2016 06 23;117(6B):E20-8. Epub 2015 May 23.

Harvard Medical School, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13144DOI Listing
June 2016

Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer.

J Clin Oncol 2016 06 11;34(16):1905-12. Epub 2016 Apr 11.

Kathryn T. Dinh, Vinayak Muralidhar, and Brandon A. Mahal, Harvard Medical School; Gally Reznor, Brandon A. Mahal, Michelle D. Nezolosky, Toni K. Choueiri, Christopher J. Sweeney, and Paul L. Nguyen, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School; Quoc-Dien Trinh, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Karen E. Hoffman, The University of Texas MD Anderson Cancer Center, Houston, TX; and Jim C. Hu, Weill Cornell Medical College, James Buchanan Brady Foundation, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.1969DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966343PMC
June 2016

Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer.

J Natl Compr Canc Netw 2016 04;14(4):421-8

Department of Radiation Oncology, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0048DOI Listing
April 2016

Association Between Very Small Tumor Size and Increased Cancer-Specific Mortality in Node-Positive Colon Cancer.

Dis Colon Rectum 2016 Mar;59(3):187-93

1 Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts 2 Division of Hematology and Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts 3 Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts 4 Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DCR.0000000000000532DOI Listing
March 2016

Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.

Int J Radiat Oncol Biol Phys 2016 Mar 14;94(4):683-90. Epub 2015 Dec 14.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.12.008DOI Listing
March 2016

Significant increase in prostatectomy and decrease in radiation for clinical T3 prostate cancer from 1998 to 2012.

Urol Oncol 2016 Feb 23;34(2):57.e15-22. Epub 2015 Oct 23.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women׳s Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.09.002DOI Listing
February 2016

Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer.

J Contemp Brachytherapy 2016 Feb 29;8(1):1-6. Epub 2016 Feb 29.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/jcb.2016.58080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793071PMC
February 2016

Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancer.

Brachytherapy 2015 Jul-Aug;14(4):511-6. Epub 2015 Apr 14.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2015.03.004DOI Listing
January 2016

Association Between Older Age and Increasing Gleason Score.

Clin Genitourin Cancer 2015 Dec 6;13(6):525-30.e1-3. Epub 2015 Jun 6.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15587673150012
Publisher Site
http://dx.doi.org/10.1016/j.clgc.2015.05.007DOI Listing
December 2015

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Authors:
Keith I Block Charlotte Gyllenhaal Leroy Lowe Amedeo Amedei A R M Ruhul Amin Amr Amin Katia Aquilano Jack Arbiser Alexandra Arreola Alla Arzumanyan S Salman Ashraf Asfar S Azmi Fabian Benencia Dipita Bhakta Alan Bilsland Anupam Bishayee Stacy W Blain Penny B Block Chandra S Boosani Thomas E Carey Amancio Carnero Marianeve Carotenuto Stephanie C Casey Mrinmay Chakrabarti Rupesh Chaturvedi Georgia Zhuo Chen Helen Chen Sophie Chen Yi Charlie Chen Beom K Choi Maria Rosa Ciriolo Helen M Coley Andrew R Collins Marisa Connell Sarah Crawford Colleen S Curran Charlotta Dabrosin Giovanna Damia Santanu Dasgupta Ralph J DeBerardinis William K Decker Punita Dhawan Anna Mae E Diehl Jin-Tang Dong Q Ping Dou Janice E Drew Eyad Elkord Bassel El-Rayes Mark A Feitelson Dean W Felsher Lynnette R Ferguson Carmela Fimognari Gary L Firestone Christian Frezza Hiromasa Fujii Mark M Fuster Daniele Generali Alexandros G Georgakilas Frank Gieseler Michael Gilbertson Michelle F Green Brendan Grue Gunjan Guha Dorota Halicka William G Helferich Petr Heneberg Patricia Hentosh Matthew D Hirschey Lorne J Hofseth Randall F Holcombe Kanya Honoki Hsue-Yin Hsu Gloria S Huang Lasse D Jensen Wen G Jiang Lee W Jones Phillip A Karpowicz W Nicol Keith Sid P Kerkar Gazala N Khan Mahin Khatami Young H Ko Omer Kucuk Rob J Kulathinal Nagi B Kumar Byoung S Kwon Anne Le Michael A Lea Ho-Young Lee Terry Lichtor Liang-Tzung Lin Jason W Locasale Bal L Lokeshwar Valter D Longo Costas A Lyssiotis Karen L MacKenzie Meenakshi Malhotra Maria Marino Maria L Martinez-Chantar Ander Matheu Christopher Maxwell Eoin McDonnell Alan K Meeker Mahya Mehrmohamadi Kapil Mehta Gregory A Michelotti Ramzi M Mohammad Sulma I Mohammed D James Morre Vinayak Muralidhar Irfana Muqbil Michael P Murphy Ganji Purnachandra Nagaraju Rita Nahta Elena Niccolai Somaira Nowsheen Carolina Panis Francesco Pantano Virginia R Parslow Graham Pawelec Peter L Pedersen Brad Poore Deepak Poudyal Satya Prakash Mark Prince Lizzia Raffaghello Jeffrey C Rathmell W Kimryn Rathmell Swapan K Ray Jörg Reichrath Sarallah Rezazadeh Domenico Ribatti Luigi Ricciardiello R Brooks Robey Francis Rodier H P Vasantha Rupasinghe Gian Luigi Russo Elizabeth P Ryan Abbas K Samadi Isidro Sanchez-Garcia Andrew J Sanders Daniele Santini Malancha Sarkar Tetsuro Sasada Neeraj K Saxena Rodney E Shackelford H M C Shantha Kumara Dipali Sharma Dong M Shin David Sidransky Markus David Siegelin Emanuela Signori Neetu Singh Sharanya Sivanand Daniel Sliva Carl Smythe Carmela Spagnuolo Diana M Stafforini John Stagg Pochi R Subbarayan Tabetha Sundin Wamidh H Talib Sarah K Thompson Phuoc T Tran Hendrik Ungefroren Matthew G Vander Heiden Vasundara Venkateswaran Dass S Vinay Panagiotis J Vlachostergios Zongwei Wang Kathryn E Wellen Richard L Whelan Eddy S Yang Huanjie Yang Xujuan Yang Paul Yaswen Clement Yedjou Xin Yin Jiyue Zhu Massimo Zollo

Semin Cancer Biol 2015 Dec;35 Suppl:S276-S304

Centro di Ingegneria Genetica e Biotecnologia Avanzate, Naples, Italy; Department of Molecular Medicine and Medical Biotechnology, Federico II, Via Pansini 5, 80131 Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2015.09.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819002PMC
December 2015

Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed Patients.

Int J Radiat Oncol Biol Phys 2015 Nov 29;93(4):828-35. Epub 2015 Jul 29.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.07.2281DOI Listing
November 2015

Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer.

J Urol 2015 Aug 11;194(2):343-9. Epub 2015 Feb 11.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2015.02.015DOI Listing
August 2015

Conditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis.

Radiat Oncol 2015 Jul 30;10:155. Epub 2015 Jul 30.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, 75 Francis St, Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13014-015-0470-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518568PMC
July 2015

Transfusion in head and neck free flap patients: practice patterns and a comparative analysis by flap type.

Otolaryngol Head Neck Surg 2015 Mar 27;152(3):449-57. Epub 2015 Jan 27.

Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA Department of Otology and Laryngology, Harvard Medical School, Boston, Massachusetts, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0194599814567107DOI Listing
March 2015

Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation.

Mol Cell 2015 Jan 4;57(1):95-107. Epub 2014 Dec 4.

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2014.10.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289430PMC
January 2015